Frequency and association of dermatological manifestations of type 2 diabetes mellitus with body mass index and HbA1c levels
Keywords:
Dermatological manifestations, type 2 diabetes mellitus, glycosylated hemoglobin, body mass indexAbstract
Objective To determine the frequency of cutaneous manifestations in patients suffering from type 2 diabetes mellitus and to observe the association of these manifestations with body mass index (BMI) and glycosylated hemoglobin (HbA1c) level. Methods This cross-sectional study was conducted in Shalamar Teaching Hospital / Shalamar Medical and Dental College, Lahore from October 2016 to March 2017. A total of 200 adult patients belonging to both genders having type 2 diabetes mellitus attending the outpatient department were studied. Detailed history and cutaneous examination was performed after taking the informed consent. Glycemic profiles including HbA1c were done. Height and weight were recorded too. Normal range of HbA1c was taken as 5 - 6.5 %. Value of ≥ 6.5 % was taken as high. Normal range of BMI as taken as 18.5- 24.9 kg/m2. Patients having BMI 25-29.9 kg/m2 were taken as overweight and ≥ 30 kg/m2 as obese. Results Of 200 patients, 174 (87%) patients were found to have cutaneous abnormalities. There were 53 (26.5%) males and 147 (73.5%) females. Mean age was 52.4±9.96 years. Mean HbA1c was 9.07±2.23%. The mean BMI was 29.46 kg/m2 with 20% having normal BMI, 38% were overweight and 41% were obese. Most frequently observed skin disease was cutaneous infections including bacterial and fungal infections, followed by generalized xerosis, diabetic dermopathy, acanthosis nigricans, pruritus and acrochordons. Statistically significant correlation was observed between HbA1c and diabetic foot and between BMI and acanthosis nigricans and generalized xerosis. Conclusion About 87% patients with type 2 diabetes have cutaneous lesions, the most common of which was cutaneous infections. Hyperglycemia manifested with high HbA1c and obesity manifested with high BMI is associated with many cutaneous lesions.References
American Diabetes Association, screening for type 2 diabetes. Diabetes Care 2004; (supp 1):S11-S13.
Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87:4–14.
Paron NG, Lambert PW. Cutaneous manifestation of diabetes mellitus. Prim care 2000; 27: 371-83.
Mather HM, Keen H: The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J (Clin Res Ed) 1985; 291:1081–4.
Kalra S, Peyrot M, Skovlund S. Second diabetes attitudes, wishes and needs (DAWN2) study: relevance to Pakistan. J Pak Med Assoc 2013; 63:1218-9.
International Diabetes Federation. Diabetes Atlas 5th Edition (2012) [cited 2016 December 18]. Available from http:// www.idf.org/diabetesatlas/5e/Update2012.
Jennifer L, John E. Diabetes mellitus. In: Irvin MF, Arthur Z, Klaus W, Austen KF, Goldsmith LA, Katz SI, editors. Dermatology in General Medicine, 6th ed. Mc Graw Hill. Medical Publishing Division: Newyork;2003. P.1651-61.
Greenwood AM. A study of skin in 500 diabetics. JAMA 1927;89:774-9
Yosipovitch G, Hodak E, Vardi P, Shraga I, Karp M Sprechere, et al. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care 1998;21:506-9.
Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1994; 30:519-31.
Goyal A, Rania S, Kaushal SS, Mahanjan V, Sharma NL. Pattern of cutaneous manifestations in diabetes mellitus. Indian J Dermatol 2010;55(1):39-41
Sasmaz S, Buy Ukbese MA, Cetin Kaya A. The prevalence of skin disorders in type -2 diabetic patients. Indian J Dermatol 2005;3: 3-8
Wahid Z, Kanjee A. Cutaneous manifestations of diabetes mellitus. J Pak Med Assoc 1998; 48:304-5
Deepika, Gupta SK, Singh P, Monika. Pattern of dermatological diseases in patients of diabetes mellitus. J Pak Med Asso 2016;26(3):214-18
Chatterjee N, Chattopadhyay C, Sengupta N, Das C, Sarma N, Pal SK. An observational study of cutaneous manifestations in diabetes mellitus in a tertiary care hospital of Eastern India. Indian J Dermatol 2014:18:217-20
Ghosh K, Das KD, Ghosh S, Chakraborty S, Jatua SK, Bhattacharya A et al. Prevalence of skin changes in diabetes mellitus and its correlation with internal diseases: A single center observational study. Indian J Dermatol 2015;60:465-9
Naheed T, Akbar N, Akbar N, Shehzad M, Jamil S, Ali T. Skin manifestations amongst diabetic patients admitted in a general medical ward for various other medical problems. Pak J Med Sci 2002;18:291-6
Timshina DK, Thappa DM, Aggrawal A. A clinical study of dermatosis in diabetes to establish its markers. Indian J Dermatol.2012;57:20-5
Hosseini MS, EhsaniAH, Hosseinpanah F, Azizi F, Salami M, Khedmat H. Skin lesions in type 2 diabetic patients. Iran J Dermatol 2008;11:113-117
Vahora R, Thakkar S, Marfatia Y. Skin, a mirror reflecting diabetes mellitus: A longitudinal study in a tertiary care hospital in Gujrat. Indian J Endocr Metab 2013;17:659-64
Majeed N, Iqbal z, Mahboob Atyia. Frequency and association of cutaneous manifestations of diabetes mellitus with HbA1c. Proceeding S.Z.P.G.M.I. 2004;18(2):85-89
Niaz F, Bashir F, Shams N, Shaikh Z, Ahmed I. Cutaneous manifestations of diabetes mellitus type 2: prevalence and association with glycemic control. J Pak Med Asso 2016;26(1):4-11
Ahmad K, Muhammad Z, Qayum I. Prevalance of cutaneous manifestations of diabetes mellitus. J Ayub Med Coll Abbottabad 2009;21(2):76-9
Mahmood T, Bari ul A, Agha H. Cutaneous manifestations of diabetes mellitus. J Pak Med Asso 2005;15:227-232
Farshchian M, Farschian M, Fereydoonnejad M, Yazdanfar A, Kimyal- Asadi A. Cutaneous manifestations of diabetes mellitus:A case series. Cutis 2010;86:31-5
Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. The Lancet 2005;366:1719-24
Almobarak AO, Awadalla H, Osman M, Ahmed MH. Prevalance of diabetic foot ulceration and associated risk factors: an old and still major public health problem in Khartoum, Sudan. Ann Transl Med 2017;5(17):340
